Ju-Seog Lee, Ph.D.
Department of Systems Biology, Division of Division of Discovery Science
Education & Training
Degree-Granting Education
1999 | University of Texas, Dallas, TX, USA, PHD, Molecular and Cell Biology |
1994 | University of Texas, Dallas, TX, USA, MS, Molecular and Cell Biology |
1988 | Kyunghee University, Seoul, KOR, BS, Biology |
Experience & Service
Academic Appointments
Associate Professor, Department of Systems Biology, Division of Cancer Medicine, UT MD Anderson Cancer Center, Houston, TX, 2012 - 2018
Assistant Professor, Department of Systems Biology, Division of Cancer Medicine, UT MD Anderson Cancer Center, Houston, TX, 2006 - 2012
Other Appointments/Responsibilities
Research Fellow, National Institutes of Health, Bethesda, MD, 2005 - 2006
CRTA Fellow, National Institutes of Health, Bethesda, MD, 2001 - 2005
Graduate Research Assistant, University of Texas at Dallas, Dallas, TX, 1997 - 1998
Honors & Awards
2009 | Waun Ki Hong Award for Excellence in Team Science, UT MD Anderson Cancer Center |
2007 | V. Scholar Award, V Foundation |
2005 | Johng S. Rhim Young Investigator Award, Society for Biomedical Research |
2005 | Incorporated Scholar-in-Training Award, AACR-AFLAC |
2004 | Fellow Award for Research Excellence, National Institutes of Health |
2002 | Fellow Award for Research Excellent, National Institutes of Health |
2001 | Technology Transfer Award, National Cancer Institute |
Selected Publications
Peer-Reviewed Articles
- Fujita M, Chen M-J, Siwak DR, Sasagawa S, Oosawa-Tatsuguchi A, Arihiro K, Ono A, Miura R, Maejima K, Aikata H, Ueno M, Hayami S, Yamaue H, Chayama K, Lee J-S, Lu Y, Mills GB, Liang H, Nishizuka SS, and Nakagawa H. Proteo-genomic Characterization of Virus-associated Liver Cancers Reveals Potential Subtypes and Therapeutic Targets. Nature Communication 13(1):6481, 2022. PMID: 36309506.
Grant & Contract Support
Title: | Comparative Functional Genomics of Liver Cancer |
Funding Source: | 21C Frontier Functional Human Genome Project |
Role: | Contractor |
Title: | Characterization of gene expession patterns of microenvironment in metastasized osteoblastic prostate cancer |
Funding Source: | Department of Defense (DOD) |
Role: | Principal Investigator |
Title: | Validation of preclinical models of human bladder cancer using comparative functional genomics |
Funding Source: | Bladder Cancer SPORE Pilot Project |
Role: | Principal Investigator |
Title: | Molecular Markers of Response to Chemoradiation in Localized Esophageal Cancer |
Funding Source: | NIH/NCI |
Role: | Co-Investigator |
Title: | Systems-level characterization of bidirectional cellular communication between cancer cells and stromal cells during invasion of prostate cancer |
Funding Source: | Department of Defense (DOD) |
Role: | Principal Investigator |
Title: | Multifunctional roles of homeobox gene DLX in ovarian cancer |
Funding Source: | NIH/NCI |
Role: | Co-Investigator |
Title: | Hippo pathway as prognostic markers and potential therapeutic targets for colorectal cancer |
Funding Source: | GS Hogan Foundation |
Role: | Principal Investigator |
Title: | Validation of paclitaxel sensitivity associated with silence of Hippo pathway in ovarian cancer |
Funding Source: | Institute for personalized medicine |
Role: | Principal Investigator |
Title: | Characterization of bidirectional cellular communication between prostate cancer cells and bones cells during bone metastasis |
Funding Source: | NIH/NCI |
Role: | Principal Investigator |
Title: | Validation of prognostic markers in advanced hepatocellular carcinoma and identification of potential serological prognostic markers |
Funding Source: | UT MDACC |
Role: | Principal Investigator |
Title: | Characterization of microenvironment of breast cancer brain metastasis |
Funding Source: | V Foundation |
Role: | Principal Investigator |
Title: | Novel strategy to identify potential therapeutic targets for cancer co-opted stromal cells of breast cancer |
Funding Source: | UT MDACC |
Role: | Principal Investigator |
Title: | Hippo pathway in Hepatocellular Carcinoma |
Funding Source: | SINF |
Role: | Principal Investigator |
Title: | Development and validation of prognostic model for gastric cancer |
Funding Source: | NIH/NCI |
Role: | Principal Investigator |
Title: | Characterizing and targeting replication stress response defects in breast cancer |
Funding Source: | DOD/Congressionally Directed Medical Research Programs (DOD/CDMRP) |
Role: | Collaborator |
Title: | GLIPR1-ATM protein therapy for prostate cancer |
Funding Source: | NIH/NCI |
Role: | Collaborator |
Title: | Molecular Determinants and Clinical Implications of Breast Cancer Dormancy |
Funding Source: | Department of Defense (DOD) |
Role: | Collaborator |
Title: | Genotyping and Phenotyping of Diffuse Gastric Cancer |
Funding Source: | Taiho Pharma |
Role: | Co-Investigator |
Title: | Androgenic Regulation of White Adipose Tissue-Prostate Cancer Interactions |
Funding Source: | Department of Defense (DOD) |
Role: | Co-Principal Investigator |
Title: | Prognostic Biomarkers of Colon Cancer |
Funding Source: | Ventana Medical Systems |
Role: | Principal Investigator |
Patient Reviews
CV information above last modified February 06, 2024